Preliminary programme
THURSDAY, 14 NOVEMBER 2019 |
|
| 9:00 | Patient advocacy session (TBD) |
| 9:00 | Sponsored satellite symposium (TBD) |
| 10:30 | Coffee break |
| 11:00 | Patient advocacy session (TBD) |
| 11:00 | Sponsored satellite symposium (TBD) |
| 12:30 | Lunch |
| 13:30 | Opening session (Chairs: Fatima Cardoso, PT and Larry Norton, US) • Welcome to Lisbon (Local authority) • Opening and introduction (Fatima Cardoso, PT) • Keynote lecture (TBD) |
| 14:30 | Meaningful clinical benefit: How to define, evaluate and communicate (Chairs: Bella Kaufman, IL and Shirley A. Mertz, US) • Applying the ESMO-MBCS to ABC systemic therapies (Shani Paluch-Shimon, IL) • Optimal endpoints for ABC clinical trials: can we aim for more? (Nadia Harbeck, DE) • Optimizing clinical trial designs in ABC: reaching relevant clinical benefit (Speaker to be confirmed) • Estimating and communicating survival times for each ABC patient (Belinda Kiely, AU) • The role of big data and real-world data (George W. Sledge, US) • Panel Discussion (All) |
| 16:00 | Coffee break |
| 16:20 | Best abstract presentations (Chairs: Alberto Costa, IT/CH and and Evi Papadopoulos, CY) |
| 16:55 | Discussing the hardest issues (Chairs: Karen Gelmon, CA and Anna Cabanes, US) • When to stop and who decides? (Gabriella Pravettoni, IT) • Suicide and assisted suicide in ABC patients (Uwe Güth, CH) • Optimal end of life care (Carla Ripamonti, IT) • Panel discussion: how to support the terminal ill and family (All) |
| 18:00 | Patient advocacy session (TBD) |
| 18:00 | Sponsored satellite symposium (TBD) |
| 19:30 | Welcome cocktail |
FRIDAY, 15 NOVEMBER 2019 |
|
| 7:30 | Sponsored satellite symposium (TBD) |
| 8:30 | ABC Award and Lecture (Chair: L. Norton, US; Awardee: TBD) |
| 9:00 | Understanding and applying biology knowledge (Chair: Daniel A. Vorobiof, ZA and Gertrude Nakigudde, UG) • Next generation sequencing for clinical decisions: friend or foe (Fabrice André, FR) • Is lobular ABC a separate entity? (Sabine Linn, NL) • De novo vs. recurrent ABC (Prudence A. Francis, AU) • Biomarkers for new approaches: what have we been doing wrong? (Aleix Prat, ES) • Discussion |
| 10:10 | Coffee break |
| 10:30 | Latest news: Triple Negative ABC (Chairs: Binghe Xu, CN and Danielle Spence, AU) • Standards of care and optimal options (Hope S. Rugo, US) • New targets, new drugs (Andrew Tutt, UK) • Biology and resistance (Giuseppe Curigliano, IT) • Discussion |
| 11:25 | Managing side effects and difficult symptoms (Chairs: Jonas Bergh, SE and Renate Haidinger, DE) • Overcoming global hurdles in pain management: from morphine shortage to opioid abuse (Matti S. Aapro, CH) • Gynecological and sexual symptoms: the silent suffering (Christoph Thomssen, DE) • Fatigue and cachexia: from biology to solutions (Carlos H. Barrios, BR) • Discussion |
| 12:20 | Lunch and poster session |
| 13:30 | Latest news: Luminal ABC (Chairs: Nagi S. El Saghir, LB and Bertha Aguilar Lopez, MX) • Standards of care and optimal options (Joseph Gligorov, FR) • New targets, new drugs (Peter Schmid, UK) • Biology and resistance (Carsten Denkert, DE) • Discussion |
| 14:25 | Specific sites of metastases (Chairs: Sung-Bae Kim, KR and Gunes Kalkan, UK) • Update on systemic therapy of brain metastases (Nancy U. Lin, US) • Leptomeningeal disease (Laura Biganzoli, IT) • The role of new RT techniques for metastases treatment (Birgitte V. Offersen, DK) • Discussion |
| 15:35 | Coffee break |
| 16:00 | Latest news: HER2+ ABC (Chairs: Silvia Neciosup, PE and Ranjit Kaur, MY) • Standards of care and optimal options (Lisa A. Carey, US) • New targets, new drugs (Javier Cortés, ES) • Biology and resistance (Frédérique Penault-Llorca, FR) • Discussion |
| 17:00 | Improving monitoring of efficacy and toxicity (Chairs: Olivia Pagani, CH and Shawna Rich-Ginsberg, CA) • Implementing PROMs in clinical research and clinical practice (Lesley Fallowfield, UK) • Optimal imaging techniques for bone only disease Frédéric (E. Lecouvet, BE) • The role of liquid biopsies (Paul Mainwaring, AU) • Discussion |
| 18:00 | Patient advocacy session (TBD) |
| 18:00 | Sponsored satellite symposium (TBD) |
SATURDAY, 16 NOVEMBER 2019 |
|
| 8:30 | Consensus session (part I) (ABC5 chairs, Scientific Committee Members and Panellists) |
| 10:30 | Coffee break |
| 11:00 | Report from ABC Patient Advocacy Committee (Speaker to be confirmed) |
| 11:15 | Consensus session (part II) (ABC5 chairs, Scientific Committee Members and Panellists) |
| 12:45 | Close |
A/V RECORDING DURING THE CONFERENCE IS PROHIBITED
ABC Global Alliance
|
|
|
|
ABC5 will be followed by the ABC Global Alliance meeting: |
